Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels. (Q51343168)
Jump to navigation
Jump to search
scientific article published on 22 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels. |
scientific article published on 22 April 2013 |
Statements
1 reference
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels. (English)
1 reference
1 reference
Alessandro Ciresi
1 reference
Marco Calogero Amato
1 reference
Valentina Guarnotta
1 reference
Flavia Lo Castro
1 reference
22 April 2013
1 reference
79
1 reference
6
1 reference
845-852
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference